Faeth Therapeutics, Inc. (FTH)
19.51
+0.71
(+3.78%)
USD |
NASDAQ |
Oct 19, 15:05
Faeth Therapeutics Market Cap : 504.00M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 485.66M |
| October 15, 2026 | 532.16M |
| October 14, 2026 | 516.66M |
| October 13, 2026 | 555.67M |
| October 12, 2026 | 600.62M |
| October 09, 2026 | 672.43M |
| October 08, 2026 | 661.58M |
| October 07, 2026 | 643.76M |
| October 06, 2026 | 694.65M |
| October 05, 2026 | 700.07M |
| October 02, 2026 | 732.37M |
| October 01, 2026 | 730.30M |
| September 30, 2026 | 768.27M |
| September 29, 2026 | 725.13M |
| September 28, 2026 | 717.38M |
| September 25, 2026 | 723.32M |
| September 24, 2026 | 750.45M |
| September 23, 2026 | 815.03M |
| September 22, 2026 | 862.82M |
| September 21, 2026 | 859.98M |
| September 18, 2026 | 891.24M |
| September 17, 2026 | 907.51M |
| September 16, 2026 | 884.52M |
| September 15, 2026 | 913.71M |
| September 14, 2026 | 1.010B |
| Date | Value |
|---|---|
| September 11, 2026 | 967.19M |
| September 10, 2026 | 1.007B |
| September 09, 2026 | 933.09M |
| September 08, 2026 | 1.013B |
| September 04, 2026 | 1.035B |
| September 03, 2026 | 1.007B |
| September 02, 2026 | 1.011B |
| September 01, 2026 | 891.50M |
| August 31, 2026 | 846.55M |
| August 28, 2026 | 874.19M |
| August 27, 2026 | 871.61M |
| August 26, 2026 | 851.71M |
| August 25, 2026 | 891.76M |
| August 24, 2026 | 896.66M |
| August 21, 2026 | 826.66M |
| August 20, 2026 | 829.24M |
| August 19, 2026 | 855.33M |
| August 18, 2026 | 852.49M |
| August 17, 2026 | 846.55M |
| August 14, 2026 | 835.44M |
| August 13, 2026 | 737.53M |
| August 12, 2026 | 758.97M |
| August 11, 2026 | 40.21M |
| August 10, 2026 | 38.29M |
| August 07, 2026 | 32.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Opus Genetics, Inc. | 314.89M |
| Nuvectis Pharma, Inc. | 498.66M |
| ACADIA Pharmaceuticals, Inc. | 3.388B |
| Alnylam Pharmaceuticals, Inc. | 31.54B |
| Anika Therapeutics, Inc. | 271.41M |
Market Cap Related Metrics
| PEG Ratio | -0.0001 |
| Price to Book Value | 2.914 |
| Price | 19.51 |
| Earnings Yield | -726.0% |
| PEGY Ratio | -0.0001 |